Avidity biosciences, inc. announces pricing of public offering of common stock

La jolla, calif., aug. 3, 2021 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a price to the public of $18.00 per share.
RNA Ratings Summary
RNA Quant Ranking